Corticosteroid use in neuro-oncology: an update

Area of Science:

• Neuro-oncology
• Supportive Cancer Care

Background:

• Malignant brain tumors often lack curative treatments, making supportive therapy essential for quality of life.
• Steroids are frequently used in supportive care for their anti-edema, anti-lymphoma, and anti-emesis properties in oncology.

Purpose of the Study:

• To review the mode of action and limitations of steroid treatment in cancer supportive care.
• To discuss the challenges of steroid use in neuro-oncology, especially with emerging immunotherapies.

Main Methods:

• Review article summarizing existing literature on steroid use in cancer supportive therapy.
• Analysis of steroid mechanisms, clinical benefits, side effects, and drug interactions.

Main Results:

• Steroids effectively manage tumor-associated edema and related symptoms, offering rapid relief.
• Corticosteroids possess anti-lymphoma and anti-emesis effects, contributing to their frequent use in oncology.
• Significant side effects (cardiovascular, muscular, psychiatric) can counterbalance therapeutic benefits.

Conclusions:

• Steroid use in neuro-oncology necessitates a critical evaluation due to potential interference with novel immunotherapies like checkpoint inhibitors and vaccines.
• Careful consideration of benefits versus risks, drug interactions, and emerging treatment paradigms is crucial for optimizing patient care.